{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:09:42Z","timestamp":1789412982374,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10654-y","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:51:46Z","timestamp":1783749106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Post-viral myocarditis"],"prefix":"10.1007","volume":"31","author":[{"given":"Mateusz","family":"Sokolski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Zychla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Balcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Jakubasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Sokolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Guidetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Krupa-Zabiega\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bromage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"10654_CR1","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"ALP Caforio","year":"2013","unstructured":"Caforio ALP, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636\u20132648. https:\/\/doi.org\/10.1093\/eurheartj\/eht210","journal-title":"Eur Heart J"},{"key":"10654_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.cir.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841\u20132. https:\/\/doi.org\/10.1161\/01.cir.93.5.841","journal-title":"Circulation"},{"key":"10654_CR3","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J et al (2025) 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J 46:3952\u20134041. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf192","journal-title":"Eur Heart J"},{"key":"10654_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0046-8177(87)80363-5","volume":"18","author":"H Thomas Aretz","year":"1987","unstructured":"Thomas Aretz H (1987) Myocarditis: The Dallas criteria. Hum Pathol 18:619\u2013624. https:\/\/doi.org\/10.1016\/S0046-8177(87)80363-5","journal-title":"Hum Pathol"},{"key":"10654_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000455","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J et al (2016) Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000000455","journal-title":"Circulation"},{"key":"10654_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","volume":"18","author":"C Tsch\u00f6pe","year":"2021","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B et al (2021) Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 18:169\u2013193. https:\/\/doi.org\/10.1038\/s41569-020-00435-x","journal-title":"Nat Rev Cardiol"},{"key":"10654_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"111","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Noutsias M et al (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation 111:887\u2013893. https:\/\/doi.org\/10.1161\/01.CIR.0000155616.07901.35","journal-title":"Circulation"},{"key":"10654_CR8","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1002\/ehf2.15304","volume":"12","author":"C Karsenty","year":"2025","unstructured":"Karsenty C, Vignaud P, Brusq C et al (2025) Acute Myocarditis According to Age: Presentation, Management and Early Outcomes. ESC Heart Fail 12:2932\u20132945. https:\/\/doi.org\/10.1002\/ehf2.15304","journal-title":"ESC Heart Fail"},{"key":"10654_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/jcdd12120484","volume":"12","author":"M Wilk","year":"2025","unstructured":"Wilk M, Tymk\u00f3w R (2025) Heart Failure in the Modern Era: A Narrative Overview of Recent Research from 2022\u20132025. J Cardiovasc Dev Dis 12:484. https:\/\/doi.org\/10.3390\/jcdd12120484","journal-title":"J Cardiovasc Dev Dis"},{"key":"10654_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1030440","author":"A Badrinath","year":"2022","unstructured":"Badrinath A, Bhatta S, Kloc A (2022) Persistent viral infections and their role in heart disease. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.1030440","journal-title":"Front Microbiol"},{"key":"10654_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMc0911362","volume":"362","author":"C-T Bock","year":"2010","unstructured":"Bock C-T, Klingel K, Kandolf R (2010) Human Parvovirus B19\u2013Associated Myocarditis. N Engl J Med 362:1248\u20131249. https:\/\/doi.org\/10.1056\/NEJMc0911362","journal-title":"N Engl J Med"},{"key":"10654_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/v14020444","volume":"14","author":"H-P Schultheiss","year":"2022","unstructured":"Schultheiss H-P, Bock C-T, Aleshcheva G et al (2022) Interferon-\u03b2 Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial. Viruses 14:444. https:\/\/doi.org\/10.3390\/v14020444","journal-title":"Viruses"},{"key":"10654_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/CIRCRESAHA.124.324674","volume":"135","author":"S Heymans","year":"2024","unstructured":"Heymans S, Van Linthout S, Kraus SM et al (2024) Clinical characteristics and mechanisms of acute myocarditis. Circ Res 135:397\u2013411. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.324674","journal-title":"Circ Res"},{"key":"10654_CR14","doi-asserted-by":"publisher","first-page":"i56","DOI":"10.1093\/eurheartjsupp\/suae105","volume":"27","author":"E Ammirati","year":"2025","unstructured":"Ammirati E, Cartella I, Varrenti M et al (2025) Acute myocarditis: 2024 state of the art. Eur Heart J Suppl 27:i56\u2013i60. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suae105","journal-title":"Eur Heart J Suppl"},{"key":"10654_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2131","volume":"30","author":"N Lasrado","year":"2020","unstructured":"Lasrado N, Reddy J (2020) An overview of the immune mechanisms of viral myocarditis. Rev Med Virol 30:1\u201314. https:\/\/doi.org\/10.1002\/rmv.2131","journal-title":"Rev Med Virol"},{"key":"10654_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00048","author":"B Maisch","year":"2019","unstructured":"Maisch B (2019) Cardio-immunology of myocarditis: focus on immune mechanisms and treatment options. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2019.00048","journal-title":"Front Cardiovasc Med"},{"key":"10654_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","volume":"85","author":"MH Drazner","year":"2025","unstructured":"Drazner MH, Bozkurt B, Cooper LT et al (2025) 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. J Am Coll Cardiol 85:391\u2013431. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.080","journal-title":"J Am Coll Cardiol"},{"key":"10654_CR18","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJMra2114478","volume":"387","author":"C Basso","year":"2022","unstructured":"Basso C (2022) Myocarditis. N Engl J Med 387:1488\u20131500. https:\/\/doi.org\/10.1056\/NEJMra2114478","journal-title":"N Engl J Med"},{"key":"10654_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097717","volume":"24","author":"F Yip","year":"2023","unstructured":"Yip F, Lai B, Yang D (2023) Role of coxsackievirus B3-induced immune responses in the transition from myocarditis to dilated cardiomyopathy and heart failure. Int J Mol Sci 24:7717. https:\/\/doi.org\/10.3390\/ijms24097717","journal-title":"Int J Mol Sci"},{"key":"10654_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21726","author":"S Keramari","year":"2022","unstructured":"Keramari S, Poutoglidis A, Chatzis S et al (2022) Parvovirus B19-associated myocarditis: a literature review of pediatric cases. Cureus. https:\/\/doi.org\/10.7759\/cureus.21726","journal-title":"Cureus"},{"key":"10654_CR21","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41440-025-02115-0","volume":"48","author":"Y Matsuzawa","year":"2025","unstructured":"Matsuzawa Y, Tsujita K (2025) Impact of SARS-CoV-2 variants on viral infectivity and the role of the renin-angiotensin-aldosterone system. Hypertens Res 48:1636\u20131638. https:\/\/doi.org\/10.1038\/s41440-025-02115-0","journal-title":"Hypertens Res"},{"key":"10654_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ehf2.15048","volume":"12","author":"H Liu","year":"2025","unstructured":"Liu H, Zhou P, Huang Y et al (2025) Clinical Characteristics, Diagnosis and Short-Term Outcomes of COVID-19\u2013Associated Acute Myocarditis in China. ESC Heart Fail 12:338\u2013352. https:\/\/doi.org\/10.1002\/ehf2.15048","journal-title":"ESC Heart Fail"},{"key":"10654_CR23","doi-asserted-by":"publisher","DOI":"10.17219\/dmp\/210102","author":"MM Wilk","year":"2025","unstructured":"Wilk MM, Wilk J, Florek K, Zimoch WJ (2025) Smoldering inflammation: the silent flame driving heart failure. Dent Med Probl. https:\/\/doi.org\/10.17219\/dmp\/210102","journal-title":"Dent Med Probl"},{"key":"10654_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2478","author":"K Mone","year":"2023","unstructured":"Mone K, Reddy J (2023) The knowns and unknowns of cardiac autoimmunity in viral myocarditis. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2478","journal-title":"Rev Med Virol"},{"key":"10654_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2586","author":"C Wang","year":"2024","unstructured":"Wang C, Luo H (2024) Crosstalk between innate immunity and autophagy in viral myocarditis leading to dilated cardiomyopathy. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2586","journal-title":"Rev Med Virol"},{"key":"10654_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1392535","author":"R Thompson","year":"2024","unstructured":"Thompson R, Cao X (2024) Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1392535","journal-title":"Front Immunol"},{"key":"10654_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.734229","author":"M Canton","year":"2021","unstructured":"Canton M, S\u00e1nchez-Rodr\u00edguez R, Spera I et al (2021) Reactive oxygen species in macrophages: sources and targets. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.734229","journal-title":"Front Immunol"},{"key":"10654_CR28","doi-asserted-by":"publisher","unstructured":"Suliman BA (2024) Potential clinical implications of molecular mimicry-induced autoimmunity. Immun Inflamm Dis 12. https:\/\/doi.org\/10.1002\/iid3.1178","DOI":"10.1002\/iid3.1178"},{"key":"10654_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.59249\/BSHH8575","volume":"97","author":"C Ying","year":"2024","unstructured":"Ying C (2024) Viral Myocarditis. Yale J Biol Med 97:515\u2013520. https:\/\/doi.org\/10.59249\/BSHH8575","journal-title":"Yale J Biol Med"},{"key":"10654_CR30","doi-asserted-by":"publisher","unstructured":"Ammirati E, Frigerio M, Adler ED et al (2020) Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy. Circ Heart Fail 13. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405"},{"key":"10654_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188330","author":"X Chen","year":"2023","unstructured":"Chen X, Li Y, Deng L et al (2023) Cardiovascular involvement in Epstein\u2013Barr virus infection. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1188330","journal-title":"Front Immunol"},{"key":"10654_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pin.12868","volume":"70","author":"K Imanaka-Yoshida","year":"2020","unstructured":"Imanaka-Yoshida K (2020) Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. Pathol Int 70:1\u201311. https:\/\/doi.org\/10.1111\/pin.12868","journal-title":"Pathol Int"},{"key":"10654_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C et al (2024) TGF-\u03b2 signaling in health, disease and therapeutics. Signal Transduct Target Ther 9:61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w","journal-title":"Signal Transduct Target Ther"},{"key":"10654_CR34","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.124.323659","volume":"134","author":"P Alcaide","year":"2024","unstructured":"Alcaide P, Kallikourdis M, Emig R, Prabhu SD (2024) Myocardial Inflammation in Heart Failure With Reduced and Preserved Ejection Fraction. Circ Res 134:1752\u20131766. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323659","journal-title":"Circ Res"},{"key":"10654_CR35","doi-asserted-by":"publisher","unstructured":"Sozzi FB, Gherbesi E, Faggiano A et al (2022) Viral Myocarditis: Classification, Diagnosis, and Clinical Implications. Front Cardiovasc Med 9. https:\/\/doi.org\/10.3389\/fcvm.2022.908663","DOI":"10.3389\/fcvm.2022.908663"},{"key":"10654_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-025-02288-7","volume":"27","author":"A Talishinsky","year":"2025","unstructured":"Talishinsky A, Ajijola OA, Khalsa SS (2025) Autonomic imbalance in cardiomyopathy and heart failure: from neurobiology to precision neuromodulation. Curr Cardiol Rep 27:144. https:\/\/doi.org\/10.1007\/s11886-025-02288-7","journal-title":"Curr Cardiol Rep"},{"key":"10654_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","volume":"135","author":"A Hinton","year":"2024","unstructured":"Hinton A, Claypool SM, Neikirk K et al (2024) Mitochondrial Structure and Function in Human Heart Failure. Circ Res 135:372\u2013396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323800","journal-title":"Circ Res"},{"key":"10654_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10741-025-10519-w","volume":"30","author":"D Roman-Pepine","year":"2025","unstructured":"Roman-Pepine D, Serban AM, Capras R-D et al (2025) A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure. Heart Fail Rev 30:931\u2013954. https:\/\/doi.org\/10.1007\/s10741-025-10519-w","journal-title":"Heart Fail Rev"},{"key":"10654_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ehf2.15064","volume":"12","author":"H Xiao","year":"2025","unstructured":"Xiao H, Chen H, Liang W et al (2025) Assessing the causal effect of inflammation-related genes on myocarditis: a Mendelian randomization study. ESC Heart Fail 12:271\u2013280. https:\/\/doi.org\/10.1002\/ehf2.15064","journal-title":"ESC Heart Fail"},{"key":"10654_CR40","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1002\/ehf2.15231","volume":"12","author":"M Merlo","year":"2025","unstructured":"Merlo M, Bassetto G, Cannat\u00e0 A et al (2025) Inflammation and Genetics in Myo-Pericardial Diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases. ESC Heart Fail 12:3987\u20133999. https:\/\/doi.org\/10.1002\/ehf2.15231","journal-title":"ESC Heart Fail"},{"key":"10654_CR41","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/ehf2.14826","volume":"11","author":"R Zeng","year":"2024","unstructured":"Zeng R, Zhou Z, Liao W, Guo B (2024) Genetic Insights into the Role of Cathepsins in Cardiovascular Diseases: A Mendelian Randomization Study. ESC Heart Fail 11:2707\u20132718. https:\/\/doi.org\/10.1002\/ehf2.14826","journal-title":"ESC Heart Fail"},{"key":"10654_CR42","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR et al (2023) 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 44:3503\u20133626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194","journal-title":"Eur Heart J"},{"key":"10654_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5603\/fc.96888","volume":"19","author":"P Franczuk","year":"2024","unstructured":"Franczuk P, Sokolska JM, Tkaczyszyn M et al (2024) Stan gospodarki \u017celazowej a uszkodzenie miokardium w ostrym zapaleniu mi\u0119\u015bnia sercowego. Folia Cardiol 19:17\u201326. https:\/\/doi.org\/10.5603\/fc.96888","journal-title":"Folia Cardiol"},{"key":"10654_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11897-022-00569-8","volume":"19","author":"A Suresh","year":"2022","unstructured":"Suresh A, Martens P, Tang WHW (2022) Biomarkers for Myocarditis and Inflammatory Cardiomyopathy. Curr Heart Fail Rep 19:346\u2013355. https:\/\/doi.org\/10.1007\/s11897-022-00569-8","journal-title":"Curr Heart Fail Rep"},{"key":"10654_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12726","author":"C Butt\u00e0","year":"2020","unstructured":"Butt\u00e0 C, Zappia L, Laterra G, Roberto M (2020) Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review. Ann Noninvasive Electrocardiol. https:\/\/doi.org\/10.1111\/anec.12726","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10654_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5830\/CVJA-2018-069","volume":"30","author":"M Matshela","year":"2019","unstructured":"Matshela M (2019) The role of echocardiography in acute viral myocarditis. Cardiovasc J Afr 30:239\u2013244. https:\/\/doi.org\/10.5830\/CVJA-2018-069","journal-title":"Cardiovasc J Afr"},{"key":"10654_CR47","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2021.11.017","volume":"15","author":"C Eichhorn","year":"2022","unstructured":"Eichhorn C, Greulich S, Bucciarelli-Ducci C et al (2022) Multiparametric Cardiovascular Magnetic Resonance Approach in Diagnosing, Monitoring, and Prognostication of Myocarditis. JACC Cardiovasc Imaging 15:1325\u20131338. https:\/\/doi.org\/10.1016\/j.jcmg.2021.11.017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10654_CR48","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jchf.2024.02.012","volume":"12","author":"E Monda","year":"2024","unstructured":"Monda E, Bakalakos A, Cannie D et al (2024) Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis. JACC Heart Fail 12:1101\u20131111. https:\/\/doi.org\/10.1016\/j.jchf.2024.02.012","journal-title":"JACC Heart Fail"},{"key":"10654_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41568-024-00715-5","volume":"24","author":"AZ Munir","year":"2024","unstructured":"Munir AZ, Gutierrez A, Qin J et al (2024) Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart. Nat Rev Cancer 24:540\u2013553. https:\/\/doi.org\/10.1038\/s41568-024-00715-5","journal-title":"Nat Rev Cancer"},{"key":"10654_CR50","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/eurheartj\/ehaf315","volume":"47","author":"JR Power","year":"2026","unstructured":"Power JR, Dolladille C, Ozbay B et al (2026) Immune checkpoint inhibitor-associated myocarditis: a novel risk score. Eur Heart J 47:1050\u20131062. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf315","journal-title":"Eur Heart J"},{"key":"10654_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1037837","author":"A Cannata","year":"2022","unstructured":"Cannata A, Bhatti P, Roy R et al (2022) Prognostic relevance of demographic factors in cardiac magnetic resonance-proven acute myocarditis: a cohort study. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2022.1037837","journal-title":"Front Cardiovasc Med"},{"key":"10654_CR52","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0735-1097(85)80312-0","volume":"6","author":"MR Costanzo-Nordin","year":"1985","unstructured":"Costanzo-Nordin MR, Reap EA, O\u2019connell JB et al (1985) A nonsteroid anti-inflammatory drug exacerbates coxsackie B3 murine myocarditis. J Am Coll Cardiol 6:1078\u20131082. https:\/\/doi.org\/10.1016\/S0735-1097(85)80312-0","journal-title":"J Am Coll Cardiol"},{"key":"10654_CR53","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/heartjnl-2023-323484","volume":"110","author":"V Collini","year":"2024","unstructured":"Collini V, De Martino M, Andreis A et al (2024) Efficacy and safety of colchicine for the treatment of myopericarditis. Heart 110:735\u2013739. https:\/\/doi.org\/10.1136\/heartjnl-2023-323484","journal-title":"Heart"},{"key":"10654_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3181\/00379727-117-29696","volume":"117","author":"JG Tilles","year":"1964","unstructured":"Tilles JG, Elson SH, Shaka JA et al (1964) Effects of Exercise on Goxsackie A9 Myocarditis in Adult Mice. Exp Biol Med 117:777\u2013782. https:\/\/doi.org\/10.3181\/00379727-117-29696","journal-title":"Exp Biol Med"},{"key":"10654_CR55","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","volume":"114","author":"H Mahrholdt","year":"2006","unstructured":"Mahrholdt H, Wagner A, Deluigi CC et al (2006) Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis. Circulation 114:1581\u20131590. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.606509","journal-title":"Circulation"},{"key":"10654_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","volume":"85","author":"MH Drazner","year":"2025","unstructured":"Drazner MH, Bozkurt B, Cooper LT et al (2025) 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. J Am Coll Cardiol 85:391\u2013431. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.080","journal-title":"J Am Coll Cardiol"},{"key":"10654_CR57","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"10654_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077025","volume":"385","author":"P Heidenreich","year":"2024","unstructured":"Heidenreich P, Sandhu A (2024) Advances in management of heart failure. BMJ 385:e077025. https:\/\/doi.org\/10.1136\/bmj-2023-077025","journal-title":"BMJ"},{"key":"10654_CR59","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/ehjqcco\/qcae069","volume":"10","author":"V Shyam-Sundar","year":"2024","unstructured":"Shyam-Sundar V, Mahmood A, Slabaugh G et al (2024) Management of acute myocarditis: a systematic review of clinical practice guidelines and recommendations. Eur Heart J Qual Care Clin Outcomes 10:658\u2013668. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae069","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10654_CR60","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1002\/ejhf.70072","volume":"27","author":"C Madaudo","year":"2025","unstructured":"Madaudo C, Segev A, Bobbio E et al (2025) Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum. Eur J Heart Fail 27:3278\u20133287. https:\/\/doi.org\/10.1002\/ejhf.70072","journal-title":"Eur J Heart Fail"},{"key":"10654_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00395-019-0754-x","volume":"114","author":"JA Silverblatt","year":"2019","unstructured":"Silverblatt JA, Ziff OJ, Dancy L et al (2019) Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis. Basic Res Cardiol 114:48. https:\/\/doi.org\/10.1007\/s00395-019-0754-x","journal-title":"Basic Res Cardiol"},{"key":"10654_CR62","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati E, Cipriani M, Moro C et al (2018) Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis. Circulation 138:1088\u20131099. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035319","journal-title":"Circulation"},{"key":"10654_CR63","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","volume":"118","author":"I Kindermann","year":"2008","unstructured":"Kindermann I, Kindermann M, Kandolf R et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639\u2013648. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.769489","journal-title":"Circulation"},{"key":"10654_CR64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","volume":"393","author":"BP Halliday","year":"2019","unstructured":"Halliday BP, Wassall R, Lota AS et al (2019) Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet 393:61\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(18)32484-X","journal-title":"Lancet"},{"key":"10654_CR65","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ejhf.3475","volume":"27","author":"L Cheng","year":"2025","unstructured":"Cheng L, Hammersley D, Ragavan A et al (2025) Long-Term Follow-Up of the TRED-HF Trial: Implications for Therapy in Patients with Dilated Cardiomyopathy and Heart Failure Remission. Eur J Heart Fail 27:113\u2013123. https:\/\/doi.org\/10.1002\/ejhf.3475","journal-title":"Eur J Heart Fail"},{"key":"10654_CR66","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1002\/ehf2.15349","volume":"12","author":"A Baritussio","year":"2025","unstructured":"Baritussio A, Giordani AS, Rizzo S et al (2025) Clinical Impact of Follow-Up Endomyocardial Biopsy in Myocarditis During or After Immune-Suppressive Therapy. ESC Heart Fail 12:3707\u20133718. https:\/\/doi.org\/10.1002\/ehf2.15349","journal-title":"ESC Heart Fail"},{"key":"10654_CR67","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/FJC.0000000000001542","volume":"83","author":"E Ferone","year":"2024","unstructured":"Ferone E, Segev A, Tempo E et al (2024) Current treatment and immunomodulation strategies in acute myocarditis. J Cardiovasc Pharmacol 83:364\u2013376. https:\/\/doi.org\/10.1097\/FJC.0000000000001542","journal-title":"J Cardiovasc Pharmacol"},{"key":"10654_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10741-012-9357-4","volume":"18","author":"S Pankuweit","year":"2013","unstructured":"Pankuweit S, Klingel K (2013) Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev 18:683\u2013702. https:\/\/doi.org\/10.1007\/s10741-012-9357-4","journal-title":"Heart Fail Rev"},{"key":"10654_CR69","doi-asserted-by":"crossref","unstructured":"Chen H, Yang M, Liu J (2003) Corticosteroids for viral myocarditis. In: Chen H-S (ed) The Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK","DOI":"10.1002\/14651858.CD004471"},{"key":"10654_CR70","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM199508033330501","volume":"333","author":"JW Mason","year":"1995","unstructured":"Mason JW, O\u2019Connell JB, Herskowitz A et al (1995) A Clinical Trial of Immunosuppressive Therapy for Myocarditis. N Engl J Med 333:269\u2013275. https:\/\/doi.org\/10.1056\/NEJM199508033330501","journal-title":"N Engl J Med"},{"key":"10654_CR71","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1161\/01.CIR.92.6.1604","volume":"92","author":"H Takada","year":"1995","unstructured":"Takada H, Kishimoto C, Hiraoka Y (1995) Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Circulation 92:1604\u20131611. https:\/\/doi.org\/10.1161\/01.CIR.92.6.1604","journal-title":"Circulation"},{"key":"10654_CR72","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","volume":"103","author":"DM McNamara","year":"2001","unstructured":"McNamara DM, Holubkov R, Starling RC et al (2001) Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy. Circulation 103:2254\u20132259. https:\/\/doi.org\/10.1161\/01.CIR.103.18.2254","journal-title":"Circulation"},{"key":"10654_CR73","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00380-013-0368-4","volume":"29","author":"C Kishimoto","year":"2014","unstructured":"Kishimoto C, Shioji K, Hashimoto T et al (2014) Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels 29:336\u2013342. https:\/\/doi.org\/10.1007\/s00380-013-0368-4","journal-title":"Heart Vessels"},{"key":"10654_CR74","volume-title":"The Cochrane Database of Systematic Reviews","author":"J Robinson","year":"2003","unstructured":"Robinson J, Crumley E, Hartling L et al (2003) Intravenous immune globulin for acute myocarditis in children and adults. The Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK"},{"key":"10654_CR75","doi-asserted-by":"publisher","first-page":"10459","DOI":"10.1038\/s41598-019-46888-0","volume":"9","author":"C-Y Yen","year":"2019","unstructured":"Yen C-Y, Hung M-C, Wong Y-C et al (2019) Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis. Sci Rep 9:10459. https:\/\/doi.org\/10.1038\/s41598-019-46888-0","journal-title":"Sci Rep"},{"key":"10654_CR76","doi-asserted-by":"publisher","first-page":"105973","DOI":"10.1016\/j.biocel.2021.105973","volume":"134","author":"A Khawaja","year":"2021","unstructured":"Khawaja A, Bromage DI (2021) The innate immune response in myocarditis. Int J Biochem Cell Biol 134:105973. https:\/\/doi.org\/10.1016\/j.biocel.2021.105973","journal-title":"Int J Biochem Cell Biol"},{"key":"10654_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102763","volume":"20","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, Emmi G et al (2021) Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev 20:102763. https:\/\/doi.org\/10.1016\/j.autrev.2021.102763","journal-title":"Autoimmun Rev"},{"key":"10654_CR78","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ehjacc\/zuad102","volume":"12","author":"DA Morrow","year":"2023","unstructured":"Morrow DA, Verbrugge FH (2023) In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis. Eur Heart J Acute Cardiovasc Care 12:627\u2013628. https:\/\/doi.org\/10.1093\/ehjacc\/zuad102","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10654_CR79","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/14796678.1.5.683","volume":"1","author":"A Matsumori","year":"2005","unstructured":"Matsumori A (2005) Emerging Treatments for Viral Myocarditis. Future Cardiol 1:683\u2013692. https:\/\/doi.org\/10.2217\/14796678.1.5.683","journal-title":"Future Cardiol"},{"key":"10654_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04301-w","volume":"23","author":"W He","year":"2025","unstructured":"He W, Cui G, Chen J et al (2025) The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy: a multicenter randomized study (HYPIC trial). BMC Med 23:467. https:\/\/doi.org\/10.1186\/s12916-025-04301-w","journal-title":"BMC Med"},{"key":"10654_CR81","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/ccr3.2499","volume":"7","author":"M Mazzitelli","year":"2019","unstructured":"Mazzitelli M, Garofalo E, Bruni A et al (2019) Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report. Clin Case Rep 7:2336\u20132340. https:\/\/doi.org\/10.1002\/ccr3.2499","journal-title":"Clin Case Rep"},{"key":"10654_CR82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13054-018-2263-y","volume":"22","author":"F-P Jahns","year":"2018","unstructured":"Jahns F-P, Ben-Hamouda N, Kirsch M et al (2018) Intravenous zanamivir for influenza myocarditis and enteral malabsorption. Crit Care 22:332. https:\/\/doi.org\/10.1186\/s13054-018-2263-y","journal-title":"Crit Care"},{"key":"10654_CR83","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/jinf.2000.0672","volume":"40","author":"A Pugliese","year":"2000","unstructured":"Pugliese A, Isnardi D, Saini A et al (2000) Impact of Highly Active Antiretroviral Therapy in HIV-positive Patients with Cardiac Involvement. J Infect 40:282\u2013284. https:\/\/doi.org\/10.1053\/jinf.2000.0672","journal-title":"J Infect"},{"key":"10654_CR84","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/ehf2.15194","volume":"12","author":"G Aleshcheva","year":"2025","unstructured":"Aleshcheva G, Salih S, Baumeier C et al (2025) Discovery of miRNAs Unique to Actively Transcribed Erythroparvovirus Infection in Heart Failure Patients. ESC Heart Fail 12:1872\u20131882. https:\/\/doi.org\/10.1002\/ehf2.15194","journal-title":"ESC Heart Fail"},{"key":"10654_CR85","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","volume":"136","author":"E Ammirati","year":"2017","unstructured":"Ammirati E, Cipriani M, Lilliu M et al (2017) Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis. Circulation 136:529\u2013545. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.026386","journal-title":"Circulation"},{"key":"10654_CR86","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ehf2.15001","volume":"12","author":"M Zemkova","year":"2025","unstructured":"Zemkova M, Rob D, Dus\u00edk M et al (2025) Combined Mechanical Circulatory Support (Impella\u2009+\u2009ECMO) in Cardiogenic Shock Caused by Fulminant Myocarditis. ESC Heart Fail 12:657\u2013663. https:\/\/doi.org\/10.1002\/ehf2.15001","journal-title":"ESC Heart Fail"},{"key":"10654_CR87","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cardfail.2018.09.007","volume":"24","author":"SK Annamalai","year":"2018","unstructured":"Annamalai SK, Esposito ML, Jorde L et al (2018) The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. J Card Fail 24:706\u2013710. https:\/\/doi.org\/10.1016\/j.cardfail.2018.09.007","journal-title":"J Card Fail"},{"key":"10654_CR88","doi-asserted-by":"publisher","unstructured":"Kondo T, Okumura T, Shibata N et al (2022) Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study. J Am Heart Assoc 11. https:\/\/doi.org\/10.1161\/JAHA.121.023719","DOI":"10.1161\/JAHA.121.023719"},{"key":"10654_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237214","volume":"12","author":"G Crisci","year":"2023","unstructured":"Crisci G, Bobbio E, Gentile P et al (2023) Biomarkers in acute myocarditis and chronic inflammatory cardiomyopathy: an updated review of the literature. J Clin Med 12:7214. https:\/\/doi.org\/10.3390\/jcm12237214","journal-title":"J Clin Med"},{"key":"10654_CR90","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10554-012-0085-6","volume":"29","author":"J-F Hsiao","year":"2013","unstructured":"Hsiao J-F, Koshino Y, Bonnichsen CR et al (2013) Speckle tracking echocardiography in acute myocarditis. Int J Cardiovasc Imaging 29:275\u2013284. https:\/\/doi.org\/10.1007\/s10554-012-0085-6","journal-title":"Int J Cardiovasc Imaging"},{"key":"10654_CR91","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1007\/s00392-021-01885-0","volume":"110","author":"C Meindl","year":"2021","unstructured":"Meindl C, Paulus M, Poschenrieder F et al (2021) Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolinium enhancement by CMR. Clin Res Cardiol 110:1792\u20131800. https:\/\/doi.org\/10.1007\/s00392-021-01885-0","journal-title":"Clin Res Cardiol"},{"key":"10654_CR92","doi-asserted-by":"publisher","unstructured":"Kociol RD, Cooper LT, Fang JC et al (2020) Recognition and Initial Management of Fulminant Myocarditis. Circulation 141. https:\/\/doi.org\/10.1161\/CIR.0000000000000745","DOI":"10.1161\/CIR.0000000000000745"},{"key":"10654_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ehjci\/jev246","volume":"17","author":"JA Luetkens","year":"2016","unstructured":"Luetkens JA, Homsi R, Sprinkart AM et al (2016) Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 17:154\u2013161. https:\/\/doi.org\/10.1093\/ehjci\/jev246","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10654_CR94","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jcmg.2014.02.005","volume":"7","author":"UK Radunski","year":"2014","unstructured":"Radunski UK, Lund GK, Stehning C et al (2014) CMR in Patients With Severe Myocarditis. JACC Cardiovasc Imaging 7:667\u2013675. https:\/\/doi.org\/10.1016\/j.jcmg.2014.02.005","journal-title":"JACC Cardiovasc Imaging"},{"key":"10654_CR95","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1148\/radiol.2019190101","volume":"292","author":"B Baessler","year":"2019","unstructured":"Baessler B, Luecke C, Lurz J et al (2019) Cardiac MRI and Texture Analysis of Myocardial T1 and T2 Maps in Myocarditis with Acute versus Chronic Symptoms of Heart Failure. Radiology 292:608\u2013617. https:\/\/doi.org\/10.1148\/radiol.2019190101","journal-title":"Radiology"},{"key":"10654_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.644922","author":"F-S Chou","year":"2021","unstructured":"Chou F-S, Ghimire LV (2021) Machine learning for mortality prediction in pediatric myocarditis. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2021.644922","journal-title":"Front Pediatr"},{"key":"10654_CR97","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s10741-024-10431-9","volume":"29","author":"PM \u0141ajczak","year":"2024","unstructured":"\u0141ajczak PM, J\u00f3\u017awik K (2024) Artificial intelligence and myocarditis\u2014a systematic review of current applications. Heart Fail Rev 29:1217\u20131234. https:\/\/doi.org\/10.1007\/s10741-024-10431-9","journal-title":"Heart Fail Rev"},{"key":"10654_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13815","author":"A Porcari","year":"2022","unstructured":"Porcari A, Merlo M, Baggio C et al (2022) Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/eci.13815","journal-title":"Eur J Clin Invest"},{"key":"10654_CR99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/08465371221119713","volume":"74","author":"C Urzua Fresno","year":"2023","unstructured":"Urzua Fresno C, Sanchez Tijmes F, Shaw KE et al (2023) Cardiac Imaging in Myocarditis: Current Evidence and Future Directions. Can Assoc Radiol J 74:147\u2013159. https:\/\/doi.org\/10.1177\/08465371221119713","journal-title":"Can Assoc Radiol J"},{"key":"10654_CR100","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCRESAHA.112.267443","volume":"111","author":"MF Corsten","year":"2012","unstructured":"Corsten MF, Papageorgiou A, Verhesen W et al (2012) MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis. Circ Res 111:415\u2013425. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.267443","journal-title":"Circ Res"},{"key":"10654_CR101","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.omtm.2020.05.005","volume":"17","author":"X Nie","year":"2020","unstructured":"Nie X, He M, Wang J et al (2020) Circulating miR-4763-3p Is a Novel Potential Biomarker Candidate for Human Adult Fulminant Myocarditis. Mol Ther Methods Clin Dev 17:1079\u20131087. https:\/\/doi.org\/10.1016\/j.omtm.2020.05.005","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10654_CR102","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3881\/j.issn.1000-503X.14043","volume":"44","author":"J-H Chen","year":"2022","unstructured":"Chen J-H, He J, Zhou R, Zheng N (2022) [Expression and Significance of Circulating microRNA-29b in Adult Fulminant Myocarditis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 44:102\u2013109. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.14043","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10654_CR103","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ejhf.579","volume":"18","author":"C Besler","year":"2016","unstructured":"Besler C, Urban D, Watzka S et al (2016) Endomyocardial miR-133a Levels Correlate with Myocardial Inflammation, Improved Left Ventricular Function, and Clinical Outcome in Patients with Inflammatory Cardiomyopathy. Eur J Heart Fail 18:1442\u20131451. https:\/\/doi.org\/10.1002\/ejhf.579","journal-title":"Eur J Heart Fail"},{"key":"10654_CR104","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ejhf.1969","volume":"23","author":"G Sinagra","year":"2021","unstructured":"Sinagra G, Porcari A, Gentile P et al (2021) Viral presence-guided immunomodulation in lymphocytic myocarditis: an update. Eur J Heart Fail 23:211\u2013216. https:\/\/doi.org\/10.1002\/ejhf.1969","journal-title":"Eur J Heart Fail"},{"key":"10654_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105207","volume":"162","author":"A Khatami","year":"2022","unstructured":"Khatami A, Razizadeh MH, Ghadirali M et al (2022) Association of parvovirus B19 and myocarditis\/dilated cardiomyopathy: a systematic review and meta-analysis. Microb Pathog 162:105207. https:\/\/doi.org\/10.1016\/j.micpath.2021.105207","journal-title":"Microb Pathog"},{"key":"10654_CR106","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jacc.2020.01.036","volume":"75","author":"G Peretto","year":"2020","unstructured":"Peretto G, Sala S, Rizzo S et al (2020) Ventricular Arrhythmias in Myocarditis. J Am Coll Cardiol 75:1046\u20131057. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.036","journal-title":"J Am Coll Cardiol"},{"key":"10654_CR107","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11886-022-01680-x","volume":"24","author":"E Ammirati","year":"2022","unstructured":"Ammirati E, Buono A, Moroni F et al (2022) State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy. Curr Cardiol Rep 24:597\u2013609. https:\/\/doi.org\/10.1007\/s11886-022-01680-x","journal-title":"Curr Cardiol Rep"},{"key":"10654_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000990","volume":"6","author":"J Berg","year":"2019","unstructured":"Berg J, Lovrinovic M, Baltensperger N et al (2019) Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up. Open Heart 6:e000990. https:\/\/doi.org\/10.1136\/openhrt-2018-000990","journal-title":"Open Heart"},{"key":"10654_CR109","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.2147\/IJGM.S543878","volume":"18","author":"H Yang","year":"2025","unstructured":"Yang H, Qidamugai W, Wang L et al (2025) Angiotensin-converting enzyme inhibitors mitigate development of chronic persistent cardiac dysfunction following fulminant myocarditis: a multicenter retrospective study in China. Int J Gen Med 18:5267\u20135281. https:\/\/doi.org\/10.2147\/IJGM.S543878","journal-title":"Int J Gen Med"},{"key":"10654_CR110","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","volume":"105","author":"H-P Schultheiss","year":"2016","unstructured":"Schultheiss H-P, Piper C, Sowade O et al (2016) Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-\u03b2 treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol 105:763\u2013773. https:\/\/doi.org\/10.1007\/s00392-016-0986-9","journal-title":"Clin Res Cardiol"},{"key":"10654_CR111","doi-asserted-by":"publisher","first-page":"E495","DOI":"10.21037\/jtd.2016.06.26","volume":"8","author":"M Pozzi","year":"2016","unstructured":"Pozzi M, Banfi C, Grinberg D et al (2016) Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients. J Thorac Dis 8:E495\u2013E502. https:\/\/doi.org\/10.21037\/jtd.2016.06.26","journal-title":"J Thorac Dis"},{"key":"10654_CR112","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.transproceed.2015.12.109","volume":"48","author":"M Ting","year":"2016","unstructured":"Ting M, Wang C-H, Tsao C-I et al (2016) Heart Transplantation Under Mechanical Circulatory Support for Acute Fulminant Myocarditis With Cardiogenic Shock. Transpl Proc 48:951\u2013955. https:\/\/doi.org\/10.1016\/j.transproceed.2015.12.109","journal-title":"Transpl Proc"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10654-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:51:50Z","timestamp":1783749110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10654-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10654"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10654-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}